HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 80 filers reported holding HOMOLOGY MEDICINES INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $7,000 | -93.2% | 3,353 | -90.2% | 0.00% | – |
Q1 2022 | $103,000 | -17.6% | 34,204 | 0.0% | 0.00% | – |
Q4 2021 | $125,000 | +27.6% | 34,204 | +173.7% | 0.00% | – |
Q3 2021 | $98,000 | +157.9% | 12,495 | +142.1% | 0.00% | – |
Q2 2021 | $38,000 | -11.6% | 5,162 | +14.4% | 0.00% | – |
Q1 2021 | $43,000 | -18.9% | 4,512 | -3.2% | 0.00% | – |
Q4 2020 | $53,000 | +6.0% | 4,659 | 0.0% | 0.00% | – |
Q3 2020 | $50,000 | -45.7% | 4,659 | -23.5% | 0.00% | – |
Q2 2020 | $92,000 | +31.4% | 6,087 | +36.8% | 0.00% | – |
Q1 2020 | $70,000 | -39.1% | 4,449 | -20.2% | 0.00% | – |
Q4 2019 | $115,000 | +40.2% | 5,578 | +23.0% | 0.00% | – |
Q3 2019 | $82,000 | -7.9% | 4,535 | 0.0% | 0.00% | – |
Q2 2019 | $89,000 | +1.1% | 4,535 | +43.8% | 0.00% | – |
Q1 2019 | $88,000 | +23.9% | 3,153 | 0.0% | 0.00% | – |
Q4 2018 | $71,000 | +102.9% | 3,153 | +103.2% | 0.00% | – |
Q3 2018 | $35,000 | +9.4% | 1,552 | 0.0% | 0.00% | – |
Q2 2018 | $32,000 | – | 1,552 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,227,035 | $97,746,000 | 3.39% |
Vivo Capital, LLC | 1,159,742 | $21,687,000 | 3.07% |
SECTORAL ASSET MANAGEMENT INC | 225,000 | $4,208,000 | 0.46% |
Rock Springs Capital Management LP | 575,000 | $10,753,000 | 0.46% |
RTW INVESTMENTS, LP | 225,000 | $4,208,000 | 0.40% |
SPHERA FUNDS MANAGEMENT LTD. | 133,000 | $2,487,000 | 0.38% |
Temasek Holdings (Private) Ltd | 3,220,293 | $60,219,000 | 0.33% |
DC Investments Management, LLC | 21,436 | $401,000 | 0.27% |
ACUTA CAPITAL PARTNERS, LLC | 79,000 | $1,477,000 | 0.24% |
Monashee Investment Management LLC | 45,000 | $842,000 | 0.23% |